Advertisement

Topics

Bracket Announces New Study for Assessment of Brain Insulin Resistance in Alzheimer's Disease

02:21 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
WAYNE, Pa., Oct. 19, 2016 /PRNewswire/ -- Bracket, a leading clinical trial technology and specialty services provider with expertise in Alzheimer's Disease, announced today a new study partnership with researchers at Massachusetts General Hospital (M...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Bracket Announces New Study for Assessment of Brain Insulin Resistance in Alzheimer's Disease"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...